Skip to main content
. Author manuscript; available in PMC: 2010 Aug 16.
Published in final edited form as: J Drug Deliv Sci Technol. 2009;19(1):3–14. doi: 10.1016/s1773-2247(09)50001-9

Figure 10.

Figure 10

General design of PEG nanocarriers conjugated to SQV prodrug and biotin/retro-inverso CK-Tat9 or CK(stearate)Tat9 peptides. The prodrug is attached through a reversible ester bond, whereas the cell-penetrating peptides are attached through reducible disulfide bonds. PEG is attached through stable amide bonds and biotin is attached through PEG spacer. The nanocarrier shown here releases the SQV.